Alpha Tau Medical Ltd. Form 6-K Summary
Business Context and Reporting Period
This Form 6-K was filed by Alpha Tau Medical Ltd. on November 12, 2024, covering the month of November 2024. The filing serves to furnish the notice and proxy statement for the Company's annual general meeting of shareholders scheduled for December 17, 2024, at its headquarters in Jerusalem, Israel.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a procedural filing regarding shareholder meetings and does not contain financial performance data.
Material Changes
No material changes to financial position or operations are reported in this filing. The document focuses solely on the logistics and proposals for the upcoming annual general meeting.
Guidance, Outlook, and Risks
The filing does not contain management commentary on future guidance, outlook, risks, contingencies, or unusual items. It incorporates by reference into existing registration statements on Form F-3 and Form S-8 but does not detail specific operational risks within this text.
Key Facts for Investors
- Meeting Date: The annual general meeting is scheduled for December 17, 2024, at 3:00 p.m. Israel time.
- Location: The meeting will be held at 5 Kiryat Hamada St., Jerusalem, Israel.
- Documents Provided: The filing includes the notice and proxy statement (Exhibit 99.1) and the proxy card (Exhibit 99.2).
- Signatory: The report was signed by Uzi Sofer, Chief Executive Officer.
- Financial Data: Investors should refer to the Company's Form 20-F or other periodic reports for financial metrics, as this filing contains none.